Efficacy and safety of insulin glulisine compared with insulin lispro in children and adolescents with type 1 diabetes mellitus: a 26 week, multicenter, open, parallel clinical trial
Latest Information Update: 21 Jan 2022
At a glance
- Drugs Insulin glulisine (Primary) ; Insulin; Insulin glargine; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 29 Oct 2008 Insulin glulisine has been approved for the use in Children 4 years and older based on results from this study.
- 11 Sep 2008 Results presented at EASD
- 19 Jan 2007 Status changed from recruting